Michael T. Wotman, M.D.

Peer-Reviewed Articles

1. Lovett, JT, Wotman, MT, Westra, WH, Ahn, S, Gupta, V, Bakst, RL, Roof, S, Miles, BA, Genden, EM, Misiukiewicz, KJ, Worona, L, Ramos, E, Botzler, J, Chen, T, Posner, MR. Long-Term outcomes of induction chemotherapy–guided reduced-dose chemoradiotherapy in poor-risk HPV-Positive oropharyngeal Cancer. Oral Oncology 174, 2026. e-Pub 2026. PMID: 41564691.
2. Lovett, JT, Wotman, MT, Denu, RA, Mandava, A, Shah, H, Sebra, R, Westra, WH, Posner, MR. Development of Glioblastoma Multiforme in Patients With Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma. Cancer Reports 9(3), 2026. e-Pub 2026. PMID: 41863061.
3. Wotman MT, Khalaf A, Wang K, Meric-Bernstam F, Gillison ML, Akhave N, Kerrigan K, Ferrarotto R. Trastuzumab Deruxtecan in HER2-Low or HER2-Mutant Recurrent/Metastatic Secretory Gland Cancers of the Head and Neck: A Case Series. J Natl Compr Canc Netw:1-5, 2025. e-Pub 2025. PMID: 41213241.
4. Lovett JT, Westra WH, Roof S, Bakst RL, Sindhu K, Genden E, Wotman MT, Ivic-Pavlicic T, Ahn S, Chen T, Misiukiewicz K, Posner M. Incidence and outcomes of radiation-associated second primary malignancies in HPV-positive oropharyngeal cancer: long-term follow-up of the quarterback de-escalation trials. Oral Oncol 169:107654, 2025. e-Pub 2025. PMID: 40934671.
5. Morris VK, Xiao W, Lin K, Wong CW, Wotman MT, Holliday EB, Huey RW, Noticewala SS, Ludmir EB, Bent AH, Ludford K, Messick C, Koay EJ, Smith G, Konishi T, Bednarski B, Chang GJ, Koong AC, You YN, Das P, Gillison ML. Time Dependency for Human Papillomavirus Circulating Tumor DNA Detection after Chemoradiation as a Prognostic Biomarker for Localized Anal Cancer. Clin Cancer Res 31(12):2399-2405, 2025. e-Pub 2025. PMID: 39873618.
6. Wotman MT, Xiao W, Du RR, Jiang B, Akagi K, Liu S, Gillison ML. Development and Validation of an Assay to Quantify Plasma Circulating Tumor Human Papillomavirus DNA for 13 High-Risk Types that Cause 98% of HPV-Positive Cancers. Head Neck Pathol 19(1):25, 2025. e-Pub 2025. PMID: 39998590.
7. Dennis, MJ, Pavlick, D, Kacew, AJ, Wotman, MT, MacConaill, LE, Jones, SM, Pfaff, KL, Rodig, SJ, Eacker, S, Malig, M, Reister, E, Piccioni, D, Kesari, S, Sehgal, K, Haddad, RI, Cohen, EE, Posner, MR, Deichaite, I, Hanna, GJ. Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma. Journal of translational medicine 22(1), 2024. e-Pub 2024. PMID: 39438862.
8. Wotman, MT, Ivic-Pavlicic, T, Westra, WH, Gold, B, D’Andrea, MR, Genden, EM, Misiukiewicz, KJ, Roof, S, Taioli, E, Posner, MR. Association of human papillomavirus genotype and phylogenic clade with oropharyngeal cancer outcomes. Oncologist 29(11):966-977, 2024. e-Pub 2024. PMID: 39137148.
9. Johnson, DB, Atkins, MB, Hennessy, C, Wise-Draper, TM, Heilman, H, Awosika, JA, Bakouny, Z, Labaki, C, Saliby, RM, Hwang, C, Singh, SR, Balanchivadze, N, Friese, CR, Fecher, LA, Yoon, JJ, Hayes-Lattin, BM, Bilen, MA, Castellano, C, Lyman, GH, Tachiki, L, Shah, SA, Glover, MJ, Flora, D, Wulff-Burchfield, E, Kasi, A, Abbasi, SH, Farmakiotis, D, Viera, K, Klein, EJ, Weissman, LB, Jani, C, Puc, M, Fahey, CC, Reuben, DY, Mishra, S, Beeghly-Fadiel, A, French, B, Warner, J, Reid, S, Brown, A, Cheng, A, Croessmann, S, Davis, EJ, Enriquez, KT, Gillaspie, EA, Hausrath, DJ, Li, X, Slosky, D, Lewis, MA, Wotman, MT. Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma. BMC cancer 23(1), 2023. e-Pub 2023. PMID: 36949413.
10. Wotman M, Xiao W, Du R, Jiang B, Liu S, Gillison ML. Development and validation of an assay to quantify plasma cell-free human papillomavirus DNA for 13 high-risk types that cause 98% of HPV-positive cancer. e-Pub 2023.
11. Nagaraj G, Vinayak S, Khaki AR, Sun T, Kuderer NM, Aboulafia DM, Acoba JD, Awosika J, Bakouny Z, Balmaceda NB, Bao T, Bashir B, Berg S, Bilen MA, Bindal P, Blau S, Bodin BE, Borno HT, Castellano C, Choi H, Deeken J, Desai A, Edwin N, Feldman LE, Flora DB, Friese CR, Galsky MD, Gonzalez CJ, Grivas P, Gupta S, Haynam M, Heilman H, Hershman DL, Hwang C, Jani C, Jhawar SR, Joshi M, Kaklamani V, Klein EJ, Knox N, Koshkin VS, Kulkarni AA, Kwon DH, Labaki C, Lammers PE, Lathrop KI, Lewis MA, Li X, Lopes GL, Lyman GH, Makower DF, Mansoor AH, Markham MJ, Mashru SH, McKay RR, Messing I, Mico V, Nadkarni R, Namburi S, Nguyen RH, Nonato TK, O'Connor TL, Panagiotou OA, Park K, Patel JM, Patel KG, Peppercorn J, Polimera H, Puc M, Rao YJ, Razavi P, Reid SA, Riess JW, Rivera DR, Robson M, Rose SJ, Russ AD, Schapira L, Shah PK, Shanahan MK, Shapiro LC, Smits M, Stover DG, Streckfuss M, Tachiki L, Thompson MA, Tolaney SM, Weissmann LB, Wilson G, Wotman MT, Wulff-Burchfield EM, Mishra S, French B, Warner JL, Lustberg MB, Accordino MK, Shah DP. Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study. Elife 12:e82618, 2023. e-Pub 2023. PMID: 37846664.
12. Gulati S, Hsu CY, Shah S, Shah PK, Zon R, Alsamarai S, Awosika J, El-Bakouny Z, Bashir B, Beeghly A, Berg S, de-la-Rosa-Martinez D, Doroshow DB, Egan PC, Fein J, Flora DB, Friese CR, Fromowitz A, Griffiths EA, Hwang C, Jani C, Joshi M, Khan H, Klein EJ, Heater NK, Koshkin VS, Kwon DH, Labaki C, Latif T, McKay RR, Nagaraj G, Nakasone ES, Nonato T, Polimera HV, Puc M, Razavi P, Ruiz-Garcia E, Saliby RM, Shastri A, Singh SRK, Tagalakis V, Vilar-Compte D, Weissmann LB, Wilkins CR, Wise-Draper TM, Wotman MT, Yoon JJ, Mishra S, Grivas P, Shyr Y, Warner JL, Connors JM, Shah DP, Rosovsky RP. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19. JAMA Oncol 9(10):1390-1400, 2023. e-Pub 2023. PMID: 37589970.
13. Bakouny Z, Labaki C, Grover P, Awosika J, Gulati S, Hsu CY, Alimohamed SI, Bashir B, Berg S, Bilen MA, Bowles D, Castellano C, Desai A, Elkrief A, Eton OE, Fecher LA, Flora D, Galsky MD, Gatti-Mays ME, Gesenhues A, Glover MJ, Gopalakrishnan D, Gupta S, Halfdanarson TR, Hayes-Lattin B, Hendawi M, Hsu E, Hwang C, Jandarov R, Jani C, Johnson DB, Joshi M, Khan H, Khan SA, Knox N, Koshkin VS, Kulkarni AA, Kwon DH, Matar S, McKay RR, Mishra S, Moria FA, Nizam A, Nock NL, Nonato TK, Panasci J, Pomerantz L, Portuguese AJ, Provenzano D, Puc M, Rao YJ, Rhodes TD, Riely GJ, Ripp JJ, Rivera AV, Ruiz-Garcia E, Schmidt AL, Schoenfeld AJ, Schwartz GK, Shah SA, Shaya J, Subbiah S, Tachiki LM, Tucker MD, Valdez-Reyes M, Weissmann LB, Wotman MT, Wulff-Burchfield EM, Xie Z, Yang YJ, Thompson MA, Shah DP, Warner JL, Shyr Y, Choueiri TK, Wise-Draper TM. Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19. JAMA Oncol 9(1):128-134, 2023. e-Pub 2023. PMID: 36326731.
14. Bakouny Z, Labaki C, Bhalla S, Schmidt AL, Steinharter JA, Cocco J, Tremblay DA, Awad MM, Kessler A, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang H, Anderson-Keightly HM, El Zarif T, Alaiwi SA, Champagne C, Rosenbloom TD, Stewart PS, Johnson BE, Trinh Q, Tolaney SM, Galsky MD, Choueiri TK, Doroshow DB. Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study. Ann Oncol 33(8):836-844, 2022. e-Pub 2022. PMID: 35715285.
15. Zhu D, Wong A, Oh EJ, Ahn S, Wotman M, Sahai T, Bottalico D, Frank D, Tham T. Impact of Treatment Parameters on Racial Survival Differences in Oropharyngeal Cancer: National Cancer Database Study. Otolaryngol Head Neck Surg 166(6):1134-1143, 2022. e-Pub 2022. PMID: 34399637.
16. Van der Elst S, Bardash Y, Wotman M, Kraus D, Tham T. The prognostic impact of depression or depressive symptoms on patients with head and neck cancer: A systematic review and meta-analysis. Head Neck 43(11):3608-3617, 2021. e-Pub 2021. PMID: 34525238.
17. Bhalla S, Bakouny Z, Schmidt AL, Labaki C, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang HH, Anderson-Keightly HM, El Zarif T, Abou Alaiwi S, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB. Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study. Lung Cancer 160:78-83, 2021. e-Pub 2021. PMID: 34461400.
18. Teckie S, Wotman M, Marziliano A, Orner D, Yi J, Mulvany C, Ghaly M, Parashar B, Diefenbach MA. Patterns of alcohol use among early head and neck cancer survivors: A cross-sectional survey study using the alcohol use disorders identification test (AUDIT). Oral Oncol 119:105328, 2021. e-Pub 2021. PMID: 34077813.
19. Gogineni E, Rana Z, Wotman M, Karten J, Riegel A, Marrero M, Maduro L, Kamdar D, Frank D, Paul D, Seetharamu N, Ghaly M. Impact of stereotactic body radiation therapy on geriatric assessment and management for older patients with head and neck cancer using G8. J Geriatr Oncol 12(1):122-127, 2021. e-Pub 2021. PMID: 32593669.
20. Schmidt AL, Bakouny Z, Bhalla S, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang HH, Anderson-Keightly HM, Abou Alaiwi S, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB. Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study. Cancer Cell 38(6):769-770, 2020. e-Pub 2020. PMID: 33176161.
21. Wotman M, Herman SW, Costantino P, Tham T. The Prognostic Role of Programmed Death-Ligand 1 in Nasopharyngeal Carcinoma. Laryngoscope 130(11):2598-2606, 2020. e-Pub 2020. PMID: 32112431.
22. Valle A, Papagermanos V, Wotman M, Shani D. A case of Moyamoya disease complicated by aHUS in a patient with a history of marginal zone B-cell lymphoma: lightning strikes thrice?. BMJ Case Rep 12(12):e229194, 2019. e-Pub 2019. PMID: 31811102.
23. Tham T, Wotman M, Chung C, Ahn S, Dupuis H, Gliagias V, Movsesova T, Kraus D, Costantino P. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis. Eur Arch Otorhinolaryngol 276(10):2913-2922, 2019. e-Pub 2019. PMID: 31312922.
24. Wotman M, Ghaly M, Massaro L, Tham T, Seetharamu N, Kamdar D, Frank D, Kraus D, Teckie S. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience. Am J Otolaryngol 40(5):684-690, 2019. e-Pub 2019. PMID: 31229365.
25. Wotman M, Oh EJ, Ahn S, Kraus D, Costantino P, Tham T. HPV status in patients with nasopharyngeal carcinoma in the United States: A SEER database study. Am J Otolaryngol 40(5):705-710, 2019. e-Pub 2019. PMID: 31277887.
26. Tham T, Leung E, Khaymovich J, Mitha S, Olson C, Wotman M, Teegala S, Coury J, Costantino P. Evaluation of Time to Surgery and Its Effect on Prognosis in Head and Neck Cancer. Oncol Res Treat 42(7-8):387-395, 2019. e-Pub 2019. PMID: 31079104.
27. Tham T, Wotman M, Roche A, Kraus D, Costantino P. The prognostic effect of anatomic subsite in HPV-positive oropharyngeal squamous cell carcinoma. Am J Otolaryngol 40(4):567-572, 2019. e-Pub 2019. PMID: 31113681.
28. Tham T, Leung E, Olson C, Wotman M, Khaymovich J, Coury J, Teegala S, Costantino P. Evaluation of the prognostic utility of the combination of platelet count with mean platelet volume as a prognostic indicator in head and neck cancer. Mol Clin Oncol 10(4):457-462, 2019. e-Pub 2019. PMID: 30931118.
29. Gliagias V, Wotman M, Herman SW, Costantino P, Kraus D, Tham T. Investigating the role of octamer binding transcription Factor-4 (Oct-4) in oral cavity squamous cell carcinoma: A systematic review and meta-analysis. Am J Otolaryngol 40(2):282-288, 2019. e-Pub 2019. PMID: 30595225.
30. Tham T, Olson C, Wotman M, Teegala S, Khaymovich J, Coury J, Costantino P. Evaluation of the prognostic utility of the hemoglobin-to-red cell distribution width ratio in head and neck cancer. Eur Arch Otorhinolaryngol 275(11):2869-2878, 2018. e-Pub 2018. PMID: 30251123.
31. Wotman M, Levinger J, Leung L, Kallush A, Mauer E, Kacker A. The Efficacy of Lavender Aromatherapy in Reducing Preoperative Anxiety in Ambulatory Surgery Patients Undergoing Procedures in General Otolaryngology. Laryngoscope Investig Otolaryngol 2(6):437-441, 2017. e-Pub 2017. PMID: 29299520.
32. Cho J, Kim JY, Wotman MT, Behrman DA, Israel H. Minimally Invasive Treatment of Temporomandibular Joint Ankylosis and Fibrosis of Temporalis Muscle. N Y State Dent J 82(3):25-30, 2016. e-Pub 2016. PMID: 27348948.

Review Articles

1. Wotman M, El-Naggar A, Ferrarotto R. Targeting human EGFR 2 (HER2) in salivary gland carcinoma. Expert Rev Anticancer Ther 23(6):573-582, 2023. e-Pub 2023. PMID: 37114470.
2. Wotman M, Gold B, Takahashi M, Draper L, Posner M. Treatment of Recurrent and Metastatic HPV-Associated Squamous Cell Carcinoma. Curr Otorhinolaryngol Rep 10:208-217, 2022. e-Pub 2022.
3. Wotman M, Ghaly M, Massaro L, Tham T, Seetharamu N, Kamdar D, Frank D, Kraus D, Teckie S. Improving post-CRT neck assessment in patients with HPV-associated OPSCC (Review). Mol Clin Oncol 13(4):24, 2020. e-Pub 2020. PMID: 32765872.
4. Wotman M, Kacker A. What are the indications for the use of computed tomography before septoplasty?. Laryngoscope 126(6):1268-1270, 2016. e-Pub 2016. PMID: 26667897.
5. Wotman M, Kacker A. Should otolaryngologists pay more attention to nasal swell bodies?. Laryngoscope 125(8):1759-1760, 2015. e-Pub 2015. PMID: 25600033.

Editorials

1. Wotman MT, Miles BA, Bakst RL, Posner MR. A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma. Cancer 127(23):4330-4338, 2021. PMID: 34379804.

Abstracts

1. Wotman M, Hoff C, Bonini F, Sawyer M, Wang K, Dal Lago E, Sousa L, Ferrarotto. Efficacy of cytotoxic chemotherapy in recurrent/metastatic adenoid cystic carcinoma. ASCO.
2. Wotman M, Kacker A. The efficacy of lavender aromatherapy in reducing preoperative anxiety in ambulatory surgery patients undergoing procedures in general otolaryngology. 26th Congress of the European Rhinologic Society.
3. Wotman M, Tiriac H, Tuveson D. Evaluating the efficacy and mechanism of action of disulfiram (antabuse) in the treatment of pancreatic ductal adenocarcinoma. Zucker School of Medicine Scholarship Day.
4. Tham T, Khaymovich J, Wotman M, Olson C, Teegala S Coury J, Costantino P. Evaluation of the Prognostic Utility of the Combination of Platelet Count and the Neutrophil-to-Lymphocyte Ratio (COP-NLR) in Head and Neck Cancer. Zucker School of Medicine 5th Annual Clinical Research Poster Session.
5. Tham T, Olson C, Teegala S, Khaymovich J, Wotman M, Coury J, Costantino P. Investigation of the Relationship between Markers of Systemic Inflammatory Response and Head and Neck Tumor Characteristi. American Academy of Otolaryngology-Head & Neck Surgery Foundation.
6. Tham T, Olson C, Teegala S, Khaymovich J, Wotman M, Coury J, Costantino P. Evaluation of the Prognostic Utility of the Hemoglobin-to-Red Cell Distribution Width Ratio in Head and Neck Cancer: Multi-center Cohort Study. American Academy of Otolaryngology-Head & Neck Surgery Foundation.
7. Tham T, Olson C, Teegala S, Khaymovich J, Wotman M, Coury J, Costantino P. Markers of Systemic Inflammatory Response as Prognostic Indicators in Head and Neck Cancer: Multi-Center Cohort Study. American Academy of Otolaryngology-Head & Neck Surgery Foundation.
8. Gliagias V, Wotman M, Herman W, Costantino P, Kraus D, Tham T. The Prognostic Role of Octamer Binding Transcription Factor 4 (OCT 4) in Oral Cavity Squamous Cell Carcinoma: A Systematic Review and Meta-analysis. Zucker School of Medicine Scholarship Day.
9. Wotman M, Herman W, Costantino P, Tham T. The Prognostic Role of Programmed Death-Ligand 1 (PD-L1) in Nasopharyngeal Carcinoma: A Systematic Review and Meta-analysis. Cleveland Clinic 2019 Multidisciplinary Head & Neck Cancer Update.
10. Wotman M, Oh EJ, Ahn S, Kraus D, Costantino P, Tham T. HPV Status in Patients with Nasopharyngeal Carcinoma in the United States: SEER Database Study. American Head and Neck Society (AHNS) Annual Meeting.
11. Bardash Y, Wotman M, Kraus D, Tham T. Does Depression Affect Survival in Head and Neck Cancer? A Systematic Review and Meta-analysis. Lenox Hill Hospital 6th Evening of Research.
12. Wotman M, Maged G, Massaro L, Tham T, Seetharamu N, Kamdar D, Frank D, Kraus D, Teckie S. Management of the Neck after Definitive Chemoradiation in Patients with HPV-associated Oropharyngeal Cancer: An Institutional Experience. Lenox Hill Hospital 6th Evening of Research.
13. Gogineni E, Wotman M, Zaker R, Karten J, Riegel A, Maduro L, Kamdar D, Paul D, Seetharamu N, Ghaly M. Using the G8 screening tool to predict quality adjusted survival for elderly head and neck cancer patients treated with stereotactic body radiotherapy. 14th International Stereotactic Radiosurgery Society Congress.
14. Gogineni E, Wotman M, Rana ZH, Karten J, Riegel AC, Maduro LA, Marrero M, Kamdar D, Frank D, Paul D, Teckie S, Seetharamu N, Ghaly M. Impact of Stereotactic Body Radiation Therapy on Assessment and Management for Older Adults with Head and Neck Cancer. American Society for Radiation Oncology 61st Annual.
15. Bhalla S, Bakouny Z, Schmidt AL, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang H, Labaki C, Anderson-Keightly HM, Alaiwi SA, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB. Disruption to care of patients with thoracic malignancies: A COVID-19 and cancer outcomes study. AACR Virtual Meeting.
16. Zhu D, Wong A, Ahn SJ, Oh EJ, Wotman M, Sahai T, Bottalico D, Frank D, Tham T. Do treatment-related parameters account for racial survival differences in oropharyngeal squamous cell carcinoma?. 15th Annual Metropolitan NYC Resident Research Day Symposium.
17. Wotman M, Junn J, Westra W, Posner M. Development of Glioblastoma Multiforme in Patients with Human Papillomavirus-associated Oropharyngeal Squamous Cell Carcinoma. ISSMS Department of Medicine Research Day.
18. Karivedu V, Hsu C, Deeken JF, Jhawar SR, Stover DG, Bowles DW, Hwang C, McKay RR, Ruiz-Garcia E, Bakouny Z, Sabbah A, Klein E, Yu PP, Glover M, Wotman M, Durbin EB, Kulkarni A, Blau S, Hallmeyer S, Wise-Draper TM. Complications and severity of COVID-19 in patients with head and neck cancer (HNC): A COVID-19 and Cancer Consortium (CCC19) registry analysis. ASCO.
19. Wotman M, Gold B, D'Andrea M, Kao D, Westra W, Roof S, Misiukiewicz K, Posner MR. Association of HPV genotype and phylogenic clade with oropharyngeal cancer outcomes. ASCO.
20. Wotman M, Gold B, Ferrandino R, Albstein N, Alpert N, Junn J, Westra W, Posner M. High-Risk Non-16 Human Papillomavirus Genotypes in Head and Neck Squamous Cell Carcinoma. ISMMS Consortium for Graduate Medical Education 13th Annual Resident Research Day.
21. Dennis M, Pavlick D, Kacew A, Wotman M, Jones SM, Pfaff KL, Rodig SJ, Eacker S, Malig M, Reister E, Piccioni D, Kesari S, Sehgal K, Haddad D, Cohen E, Posner MR, Deichaite I, Hanna GJ. Clinical, molecular, and immunologic profiling of brain metastases (BM) in head and neck squamous cell carcinoma (HNSCC). ASCO.
22. Wotman M, Xiao W, Du R, Jiang B, Liu S, Gillison M. Development and validation of an assay to quantify plasma cell-free human papillomavirus DNA for 13 high-risk types that cause 98% of HPV-positive cancers. 2024 ASCO Annual Meeting.

Letters to the Editor

1. Lovett, JT, Wotman, MT, Posner, M. Misclassification of p16-positive, HPV-negative patients biases de-escalation trials. The lancet oncology 26: e623-e623, 2025.